Product Information
PROTONIX 40 MG SUSPENSION is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $14.0829 per EA under NDC 00008084402. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 14, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the PANTOPRAZOLE SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
NDC
00008084402
Classification
Brand
Dosage Form
GRANULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA022020FDA Approved
11/14/2007
TE Code
AB
On Market Since
2/29/2008
Pharmacological Classes
Price Statistics
The NADAC for PROTONIX 40 MG SUSPENSION has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 129.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.0829 per EA |
|---|---|
| All-time high | $16.6963 (Nov 29, 2023) |
| All-time low | $6.1440 (Nov 28, 2013) |
| 52-week high | $14.2436 |
| 52-week low | $13.7995 |
| Median price | $13.8581 |
| Average price | $13.0542 |
| Largest weekly change | -17.0% (Dec 6, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROTONIX 40 MG SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for PROTONIX 40 MG SUSPENSION, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $14.0829 per EA (NDC 00008084402), effective Aug 19, 2026.
How has the price of PROTONIX 40 MG SUSPENSION changed over time?
Over the history we have for it, the NADAC for PROTONIX 40 MG SUSPENSION has risen 129.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROTONIX 40 MG SUSPENSION?
Since Nov 28, 2013, the NADAC for PROTONIX 40 MG SUSPENSION has ranged from a low of $6.1440 (Nov 28, 2013) to a high of $16.6963 (Nov 29, 2023), with a median of $13.8581 per EA.
Are there cheaper alternatives to PROTONIX 40 MG SUSPENSION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PANTOPRAZOLE DR 40 MG SUSP PKT, is $4.2008 per EA — about 70% below PROTONIX 40 MG SUSPENSION.
Who manufactures PROTONIX 40 MG SUSPENSION?
PROTONIX 40 MG SUSPENSION (NDC 00008084402) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.